Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized and Placebo-Controlled Double-Blind Multicentre Study to Determine the Efficacy and Safety of VSL#3 Probiotic Food Supplement Mixture in Prevention of Endoscopic Recurrence in Crohn's Disease Patients With Ileocolonic Surgical Resection and Small Intestine to Colon Anastomosis.

NCT00175292 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT00175292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00175292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized and Placebo-Controlled Double-Blind Multicentre Study to Determine the Efficacy and Safety of VSL#3 Probiotic Food Supplement Mixture in Prevention of Endoscopic Recurrence in Crohn's Disease Patients With Ileocolonic Surgical Resection and Small Intestine to Colon Anastomosis.
Lead sponsor
University of Alberta
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2003
Completion date
Not reported
Enrollment
120 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease, inflammatory bowel disease